Patrick Rush, D.P.M.
Dr. Rush joined Excision in June 2018 as Head of Clinical Operations. He is an accomplished pharmaceutical leader and scientist with more than 20 years of clinical research experience in Phase I-IV clinical development. Dr. Rush has held positions of increasing responsibilities within Clinical Development, Project Management and Regional Monitoring. Over his career he has worked at GlaxoSmithKline, Bristol Myers-Squibb, Idenix, CanFite BioPharma and the University of Pennsylvania.
Dr. Rush received his professional degree from Temple University School of Podiatric Medicine and completed residency training at Cooper University Hospital. He received a Bachelor of Arts in Biology from Temple University.